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a  b  s  t  r  a  c  t
Annona  hypoglauca  Mart.,  Annonaceae,  popularly  known  as  “beribá”,  was  collected  in ﬂooded  areas  of  the
Amazonian  Rain Forest.  The  crude  extract  obtained  from  this  species  was found  to  be cytotoxic  against
human  cancer  cells.  Chemical  information  on  A.  hypoglauca  is  scarce.  So,  the present  work  aimed  the
isolation  and  identiﬁcation  of  its  alkaloids  and  to test  their  cytotoxic  activity.  Alkaloids  were  obtained
from  stem  by acid–base  partitioning  and  the  remaining  alkaloid-free  extract  was  partitioned  with  organic
solvents.  Gas  chromatography–mass  spectrometry  GC/MS  analysis  of  total  alkaloids  allowed  the  iden-
tiﬁcation  of four  aporphine  alkaloids:  actinodaphnine,  anonaine,  isoboldine  and  nornuciferine.  Total
alkaloids  were  fractionated  by  column  chromatography  and  were  puriﬁed  by preparative  thin-layer-
chromatography,  which  allowed  the isolation  of two  aporphine  alkaloids,  actinodaphnine  and  isoboldine,
characterized  by  NMR  and  CG–MS  analyses.  This  is the ﬁrst  report for the  occurrence  of  actinodaphnine
in  Annona  species.  All  the  samples  were  tested  in cytotoxic  and  antibacterial  assays.  Total  alkaloid  extractctinodaphnine
and its fractions  showed  antimicrobial  activity  against  Staphylococcus  aureus  and  Enterococcus  faecalis.
In  the  cytotoxicity  assay,  the crude  extract showed  a  lethal  effect  against  breast  and  colon  cancer  cells.
Isoboldine-containing  FA5  and  actinodaphnine-containing  FA6  showed  activity  against  breast  cancer  cell
line,  while  the  alkaloid-free  fractions  did  not  show  signiﬁcant  activity  against  cancer  cell  lines.
©  2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
Annonaceae is a pantropical family containing approximately
30 genera and 2300 species of trees and shrubs (Heywood, 1993;
ordell et al., 2001). The tropical American genus Annona L. is rep-
esented by 140 species, which are recognized mainly by their
dible fruits, such as A. muricata (graviola), A. squamosa (fruta-do-
onde), A. coriaceae (araticum) and A. cherimolia (cherimoya) plants
elonging to the genus Annona are also used in folk medicine as
ntitumor, anti-parasite and antidiarrhea (Pimenta et al., 2003),
ntiprotozoal (Siqueira et al., 2011), anti-inﬂammatory (Siebra
t al., 2009), cytotoxic and anti-ulcerogenic agents (Hamid et al.,
012). Some species have also been pharmacologically studied
or their platelet anti-aggregation and antiulcerogenic activities
Villar et al., 1997; Padma et al., 1998). The genus Annona is a rich
ource of isoquinoline – particularly aporphine alkaloids (Leboeuf
t al., 1982; Rabêlo et al., 2014) – and acetogenins (Bermejo et al.,
005). The structural diversity of the isoquinoline alkaloids is as
ide as the range of its biological activities, which can be used as
∗ Corresponding author.
E-mail: extractlab@unip.br (I.B. Suffredini).
http://dx.doi.org/10.1016/j.bjp.2016.08.006
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
antimicrobial (Simeón et al., 1990), cytotoxic (Wu et al., 1993),
antitumoral (Sonnet and Jacobson, 1971), antiprotozoal (Tempone
et al., 2005), antiviral (Montanha et al., 1995) besides many other
applications, especially in demonstrating antimicrobial activity
against Gram-positive bacteria (Villar et al., 1987; Abbasoglu et al.,
1991; Paulo et al., 1992).
Annona hypoglauca Mart. occurs in the ﬂooded areas (igapós) of
the northern Amazonian forests, as well as in terra ﬁrme forests.
The species can be found as a tree up to 10 m height when occur-
ring in terra ﬁrme or as a liana when occurring in the igapós where
it is popularly known as beribá (Gottsberger, 1978), or biribá,  in
the Brazilian Amazon region, or as guanábana huasca and tortuga
blanca by other South American communities, or as wild soursop,
its English name. Its fruits are eaten by locals and the tea made with
the bark is used as medicine against parasites, anemia and chronic
diarrhea (Revilla, 2002). A. mucosa, A. sylvatica, Duguetia marcgra-
viana and Fusea longifolia are also known as biribá,  in Brazil (Reﬂora,
2016).
Previous biological screening aiming the identiﬁcation of cyto-
toxicity of 1277 Amazon plant extracts against human breast
cancer cell lines (Suffredini et al., 2007a), prostate cancer cell lines
(Suffredini et al., 2006a), colon, lung, central nervous system and
leukemia cancer cell lines (Suffredini et al., 2007b) have been made,
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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ogether with the evaluation of the antimicrobial activity of the
xtracts against some pathogenic microorganisms as Staphylococ-
us aureus (Suffredini et al., 2004), Enterococcus faecalis (Castilho
t al., 2013, 2014), Streptococcus mutans (Barnabé et al., 2014)
nd Escherichia coli (Camargo and Suffredini, 2014). From the pre-
ious screening, the crude extract obtained from the stem of A.
ypoglauca Mart., Annonaceae, the so-called EB1109, has shown a
igniﬁcant activity against breast cancer cell line MCF-7 (Suffredini
t al., 2007a) and against S. mutans (Barnabé et al., 2014). Despite
hese ﬁrst results, little is known about the chemical composition
nd biological activities of A. hypoglauca, despite a wide literature
onsidering other Annona species.
The present study aims to report the isolation of aporphine alka-
oids from the stems of A. hypoglauca, as well as to report the
ytotoxic activity of EB1109 and its fractions. As literature also
ndicates a putative antimicrobial activity related to the Annona
lkaloids, all samples were also tested against the pathogenic bacte-
ia.
aterials and methods
lant material
The stem of Annona hypoglauca Mart., Annonaceae, was  col-
ected in water-ﬂooded forests (named igapó forest), Amazon
ain forest, Manaus, (Lat. 2◦58′ and Long. 60◦27′), Anavilhanas
cological Station). A voucher specimen was deposited under
dentiﬁcation number [AAOliveira, 3577 (UNIP Herbarium] and
as identiﬁed by Dr. Mateus L. B. Paciencia. Plant collection was
one under Brazilian Government plant collect license number
MA/ICMBio/SISBIO#14895 and license to access genetic material
bama/MMA/CGen#012A-2008.
xtraction procedures
Crude extract: The stems of the plant (1.074 kg) were air-dried
t 40 ◦C in an air-circulating oven. Plant material was ground in a
ammer mill before being submitted to 24 h maceration with 10 l
f a mixture containing dichloromethane:methanol (1:1, v/v). The
esulting organic extract was concentrated to dryness (46.14 g) and
ielded 4.3% of EB1109 (Younes et al., 2007).
Total alkaloid fraction (TA): EB1109 (5 g) were extracted with
0 ml  0.1 M phosphoric acid under agitation for 30 min. Extraction
as repeated four times. Acid solutions were ﬁltered and reunited
o the same funnel. Acid solution was three times extracted with
0 ml  hexane in order to have non-polar compounds removed.
he acid solution was brought to pH ∼ 9 with ammonia hydrox-
de solution (25%, w/w) and was partitioned with portions of 50 ml
hloroform, until negative to Dragendorff’s reagent. The organic
hase was dried with anhydrous sodium sulphate and concentrated
o give the total alkaloid (TA) fraction (3.1 g; 0.28%). TA yield was
btained considering the crude plant material.
Alkaloid-free extracts: The cake, considered as the remaining
nsoluble material resulted from the alkaloid extraction, was dried
nd the remaining solids were dissolved in a series of solvent
ystems. Hexane (30 ml)  was added to the cake and the sys-
em remained under agitation for 30 min. After that, the system
as decanted and ﬁltered. This procedure was repeated three
imes under the same conditions. The combined hexane solutions
ere evaporated and originated fraction hexane (FHex, 2.64 g;
.25%). A second dissolution done in a similar way was  performed
ith a mixture of dichloromethane (DCM) and methanol (MeOH)
1:1, v/v), resulting fraction DCM/MeOH (DCM/MeOH; 1.71 g;
.16%). The third dissolution was made with ethyl acetate, result-
ng in fraction FEAC (0.21 g; 0.02%). Finally, the remaining cakeFarmacognosia 27 (2017) 77–83
material was partitioned with a 20% ethanol:H2O solution and
extracted with three portions of 250 ml  each of butanol, originating
the fraction butanol (FBuOH; 0.65 g; 0.06%). Fractions yields were
obtained considering the crude plant material.
Isolation of alkaloids
TA (2 g) was fractionated by column chromatography (70 cm
length x 40 mm diameter) on 50 g normal phase silica gel 60. Elution
was made with the following solvent mixtures: DCM  and MeOH
in order of increasing polarity, as follows: 100% DCM (200 ml),
DCM:MeOH 9:1 (400 ml), DCM:MeOH 8:2 (400 ml), DCM:MeOH
7:3 (400 ml), DCM:MeOH 1:1 (400 ml)  and 100% MeOH (200 ml).
The elution resulted in the following fractions: 100% DCM yielded
fraction 1 (FA1, 7.6 mg;  0.0011%); DCM:MeOH 9:1 (v/v) yielded
fractions 2 (FA2, 0.4 mg;  0.00005%) and 3 (FA3, 738.4 mg;  0.1055%);
DCM:MeOH 8:2 (v/v) yielded fractions 4 (FA4, 161.4 mg;  0.0231%)
and 5 (FA5, 176.1 mg;  0.0252%); DCM:MeOH 7:3 (v/v) yielded frac-
tions 6 (FA6, 395.8 mg;  0.0565%) and 7 (FA7, 43.4 mg; 0.0062%);
and ﬁnally fractions 8 (FA8, 26.9 mg;  0.0038%), 9 (FA9, 22.1 mg;
0.0031%) and 10 (FA10, 16.0 mg;  0.0023%) were eluted with
DCM:MeOH 1:1 (v/v). Fractions yields were obtained considering
the crude plant material.
Fractions FA4, FA5 and FA6 were again fractionated using
preparative thin layer chromatography (PTLC) precoated with
1 mm of silica gel 60F254, without being activated and a solvent mix-
ture of CHCl3:MeOH (92:8) as mobile phase. Spots were observed
under U.V. light ( = 366 nm)  and revealed after reaction with Dra-
gendorff’s reagent. Bands related to each isolated compound were
eluted with DCM and were then submitted to RMN  analysis. Frac-
tion FA4 originated four fractions, FA5 originated three fractions,
and FA6 originated six fractions. Compound 1 was  then isolated
from FA5.2 using PTLC as a brown amorphous solid (3.7 mg). Com-
pounds 2 and 3 were analyzed by 1H NMR  as a mixture. Lastly,
compound 4 was  isolated from FA6.2, obtained from preparative
TLC, as a light brown amorphous solid (7.8 mg). Four alkaloids were
identiﬁed.
Compound 1, isoboldine: (1H NMR, 300 MHz, CDCl3, TMS  inter-
nal standard): ı 7.94 (1H, s, H-11), 6.74(1H, s, H-8), 6.47 (1H, s, H-3),
3.84–3.85 (6H, s,br, OMe-10 and OMe-2), 2.49 (3H, s, N-CH3) (Soares
et al., 2015; Jackson and Martin, 1966); 13C NMR  (75 MHz, CDCl3):
ı 145.74 (C-2), 144.90 (C-9), 144.43 (C-10), 140.47 (C-1), 129.7 (C-
7a), 124.4 (C-11a), 119.7 (C-1a), 113.87 (C-11), 111.55 (C-8), 108.64
(C-3), 62.51 (C-6a), 56.16 (C-2 OMe), 56.09 (C-10 OMe), 53.36 (C-5),
43.80 (C-6 N-CH3), 33.9 (C-7), 28.79 (C-4)) (Jackman et al., 1979).
MS/EI (M+) RT = 27.99: 327 (M+), 326 (M+-1), 310 (M+-17), 284
(M+-43), 269 (M+-58), 253 (M+-74).
Compound 2, nornuciferine (present in fraction FA5.3): (1H
NMR, 200 MHz, CDCl3, TMS  internal standard): ı 8.32 (1H, d,
J = 7.8 Hz, H-11), 7.28 (1H, m,  H-8, H-9, H-10), 6.58 (1H, s, H-3), 3.59
(3H, s, 2-OCH3), 3.32 (3H, s, 1-OCH3) (Dutra et al., 2012; Hasrat et al.,
1997). MS/EI (M+) RT = 20.12: 281 (M+), 280 (M+-1), 266 (M+-15),
250 (M+-31), 237 (M+-43), 221, 178, 165, 152.
Compound 3, anonaine (present in fraction FA5.3): (1H NMR,
200 MHz, CDCl3, TMS  internal standard): ı 8.00 (1H, d, J = 7.8 Hz;
H-11), 7.28–7.14 (1H, m,  H-8, H-9, H-10), 6.68 (1H, s, H-3), 5.89
(1H, d, J = 0.8 Hz, 1-OCH2O-2) and 6.28 (1H, d, J = 0.8 Hz, 1-OCH2O-
2,) (Costa et al., 2012; Hasrat et al., 1997). MS/EI (M+) RT = 21.32:
265 (M+), 254 (M+-1), 236 (M+-29).
Compound 4, actinodaphnine: (1H-NMR, 300 MHz, CDCl3, TMS
internal standard): ı 7.56 (1H, s, H-11), 6.73(1H, s, H-8), 6.45
(1H, s, H-3), 6.01 (1H, app. s, 1-OCH2O-2), 5.86 (1-H, app. s, 1-
OCH2O-2), 3.92 (1H, dd,  J = 13.92, 5.16 Hz, H-6a), 3.85 (3-H, s,
OMe-10), 3.46 (1H, s,br, NH-6), 3.38 (1H, d br, J = 7.77, H-5eq),
2.97 (2H, d br, J = 8.88, H-5ax, H-4eq), 2.82 (1H, d br, J = 13.92,
H-7eq), 2.61 (2H, d br, J = 12.05, H-4ax, H-7 ax); 13C-DEPT 135
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300 MHz, CDCl3): CH: ı 114.4; 110.1; 106.9; CH3: 56.1; 53.3; CH2:
00.6; 42.55; 35.4; 28.3. 13C NMR  (75 MHz,CDCl3): ı 146.99 (C-
), 145.65 (C-10), 145.35 (C-9), 141.70 (C-1), 128.09 (C-7a), 125.98
C-1b), 125.65 (C-3a), 122.74 (C-11a), 116.57 (C-1a), 114.41 (C-8),
10.11 (C-11), 106.96 (C-3), 100.62 (OCH2O), 56.08 (C-10 OMe),
3.27 (C-6a), 42.56 (C-5), 35.37 (C-7), 28.32 (C-4)) (Stévigny et al.,
002). MS/EI (M+) RT = 27.48: 311 (M+), 310 (M+-1), 279, 251, 181.
NCH3
H3CO
HO
OH
H3CO
1
NH
O
O
NH
H3CO
H3CO
2
NH
OH
H3CO
O
O
43
pectroscopic analysis
NMR  spectra of 1H and 13C were obtained on a Bruker spectrom-
ter, operating at 200 MHz  or at 300 MHz  (1H) and at 75 MHz  (13C).
C–MS was performed in an Agilent Series 6890 chromatograph,
quipped with a HP-5 column (30 m × 0.25 mm,  ﬁlm of 0.25 m),
he injector was set to 290 ◦C, the carrier gas (He) ﬂow was adjusted
o 1 ml/min, the initial temperature was 95 ◦C for 2 min, followed by
n increment of 8 ◦C/min until 310 ◦C, the temperature was main-
ained for 2 min. The MS  detector operated in the electron impact
EI; 70 eV), was used to qualitative evaluate the alkaloid contents.
iological assays
amples preparation
Sample preparation for cytotoxic assay: all the samples were
iluted to 2 mg/ml  in 50% dimethylsulfoxide (DMSO) in water
efore being evaluated in a single-concentration assay (ﬁnal test
oncentration 100 g/ml). Sample preparation for antibacterial
ssay: samples were diluted in DMSO50% to the following concen-
rations of 200, 180, 160, 140, 120, 100, 80, 60, 40 and 20 mg/ml,
n order to proportionate ﬁnal test concentrations of 100, 90, 80,
0, 60, 50, 40, 30, 20 and 10 g/ml. Vehicle was tested for its
ntimicrobial activity, as well as doxorubicin (Adriamicin®) at a
oncentration of 25 mM was used as standard drug in the cytotox-
city assay and gentamycin and tetracycline prepared at various
oncentrations were used as standard drugs in the antibacterial
ssay. Antibiotic ﬁnal test concentrations for MIC/MBC assay ranged
rom 120 g/ml down to 0.16 g/ml.Farmacognosia 27 (2017) 77–83 79
Antibacterial microdilution broth assay
Tests were performed in aseptic conditions (Suffredini et al.,
2015). Bacteria inoculum was prepared at the concentra-
tion of 1.5 × 102 CFU/ml, starting from a 0.5 McFarland (or
1.5 × 108 CFU/ml), as follows (Younes et al., 2007). S. aureus
(ATCC 29213), Escherichia coli (ATCC 25922) and E. faecalis (ATCC
29212) were the bacterial strains tested. Bacteria inoculum of
each strain was  obtained from fresh 24-h culture colonies grown
on Müeller-Hinton agar plates. Each strain was inoculated into
5 ml  of Müeller–Hinton broth in order to obtain a concentra-
tion of 1.5 × 108 CFU/ml (0.5 McFarland), which was determined
by a turbidimeter (Oxoid) adjusted to the 0.5 McFarland con-
centration. Each inoculum was  then diluted in broth medium to
1.5 × 102 CFU/ml. One hundred and ninety microliters of this sus-
pension was transferred to each microplate well. Ten microliters of
each treatment were added to the microplate wells and incubated
at 35 ◦C for 18–20 h. Treatments that have visually inhibited bacte-
ria from grow were subcultured in Müeller-Hinton agar plates that
were incubated at 35 ◦C for 18 to 20 h. Observations of bacteria grow
or lack of bacteria grow determined which treatment was effective.
All samples that showed effectiveness in the single-concentration
assay were submitted to the determination of MIC  and MBC.
Determination of minimal inhibitory concentration and minimal
bactericidal concentration
Minimal inhibitory concentration (MIC) and minimal bacteri-
cidal concentration (MBC) were determined for the treatments that
showed total growth inhibition in the single-concentration assay
using the protocol described above. The same protocol was used
to determine MIC  and MBC. Samples were prepared in concentra-
tions of 0.2 up to 2 mg/ml, in a 0.200 mg/ml  fold (test concentrations
ranging from 10 to 100 g/ml, in 10 g/ml fold) were evaluated.
Turbidity was observed and those identiﬁed as having a visual
lack of turbidity were subcultured in Müeller–Hinton agar Petri
dishes, which were then incubated at 35 ◦C for 18–20 h. After the
incubation, bacteria growth was  determined and supported the
establishment of MIC’s and MBC’s as follows: the lower concentra-
tion observed as having a lack of turbidity but presenting bacteria
growth was  determined as the MIC  and the lower concentration
having a lack of turbidity and did not present any bacteria growth
after subculture was  considered as the MBC.
Cytotoxicity assay
The original method (Monks et al., 1991) was adapted
(Suffredini et al., 2006b) for speciﬁc cell lines. Human tumor cell
lines (MCF-7, breast adenocarcinoma; KM-12, colon adenocarci-
noma; RPMI-8226, multiple myeloma; PC-3, prostate carcinoma;
SF-268 glioblastoma and NCI-H460, non-small lung-cell carci-
noma), obtained from the National Cancer Institute (Frederick, MD,
USA), were maintained in RPMI-1640 medium supplemented with
10% bovine fetal serum, 1% l-glutamine and 1% gentamycin, at 37 ◦C,
5% CO2 and 100% relative humidity. Cell density was  measured in
a Neubawer chamber using the trypan blue exclusion method for
each cell line. Cell density (per well per 100 l) varied according to
each cell line, for the assay: PC-3 (7500); KM-12 (15,000); NCI-H460
(7500); SF-268 (15,000) and RPMI-8226 (20,000) (Monks et al.,
1991). So, 100 l of cell suspension was transferred to each well
of 96-well plates, following the established cell density described
above. Plates were incubated at 37 ◦C, 5% CO2 and 100% relative
humidity for 24 h. One of the plates were ﬁxed with 50 l of cold
50% (adherent cells) or 80% (non-adherent cell) trichloroacetic acid
(TCA) in order to obtain time zero cell growth, corresponding to
the time immediately before treatment addition. So, 100 l of each
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reatment (extract, fractions, isolates or doxorubicin) was  added
o the wells in sextuplicates. Also, in order to obtain a better
xperiment control, two wells having only medium plus treat-
ent were added to the plates, as well as 16 wells containing
edium plus cells without treatment, in order to establish a reg-
lar cell grow (positive control). Plates were kept incubating for
8 h before evaluation. After that, plates were also ﬁxed with TCA at
he pre-stipulated concentration. TCA was removed with water and
ulforodamine B (SRB) colorimetric assay was performed. Accord-
ng to Voigt (2005), the protein dye SRB assay is currently used
or measuring drug-induced cytotoxicity and cell proliferation for
inding electrostatically and pH dependent to protein basic amino
cid residues of TCA-ﬁxed cells in a linear correspondence to the
mount of cells. So, time zero (T0), cell control (C) and treatment (T)
ptical densities at 515 nm were used to calculate the percentage
f cell grow inhibition or, as follows: [(T − T0)/(C − T0) × 100 = % of
rowth]. Results were interpreted by the comparison of cell growth
fter treatment (T) to positive control cells (C), both considering cell
rowth at Time Zero (T0). If 100 > T > T0 was observed the presence
f cell growth inhibition; if T = T0 = 0 was observed that cells do not
row in relation to the cell density at T0; if T < T0, it means that
reatment is effective enough to cause cell lethality. Treatments
ere evaluated at a speciﬁc test concentration of 100 g/ml.
esults and discussion
The alkaloid yield from A. hypoglauca stems was 0.28%. Pre-
ious studies (Debourges et al., 1987) relate yields ranging from
.3% and 0.2% for Duguetia species, while (Fischer et al., 2004)
escribes yields of 0.5% for Annona. The yield of total alkaloids
ere obtained from A. hypoglauca is somewhat among the expected
alues.
TA fraction was analyzed by gas GC–MS, and the presence of four
porphine alkaloids could be determined: isoboldine (1) isolated
rom FA5.2, nornuciferine (2) and anonaine (3), identiﬁed as mix-
ure in fraction FA5.3 and actinodaphnine (4), isolated from FA6.2.
ompounds were characterized by the comparison of their frag-
entation pattern in the mass spectra (MS) to the library from the
quipment (Wiley 25) and to the literature data. Major compound
Rt 20.12 min) showed the following fragmentation pattern: m/z
81 (M+.), 280 (M+-1), 266 (M+-15), 250 (M+-30), 252 (M+-29), 237,
21, 178, 165, 152 which is compatible to nornuciferine (2). The
eak at m/z  280 with 100% intensity is characteristic of aporphines,
hich easily lose the hydrogen next to the NH group at C-6a (Ohashi
t al., 1963). Nornuciferine (2) was isolated from A. hayesii stem as
able 1
inimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) f
lkaloid fractions against three bacteria strains.
Extracts and fractions Staphylococcus aureus
ATCC 29213
MIC  (g/ml) MBC (g/ml) 
Crude extract >100 >100 
FHex  >100 >100 
DCM/MeOH >100 >100 
FEAC  >100 >100 
FBuOH >100 >100 
Total  alkaloids 60 70 
FA4.4  NT NT 
FA5a 70 70 
FA6a 70 80 
Gentamycin 0.20 0.20 
Tetracyclin 0.50 0.50 
IC, minimal inhibitory concentration; MBC, minimal bactericidal concentration, NT, not t
EAC,  fraction ethyl acetate, FBuOH, fraction butanol.
a FA5 and FA6 are column fractions obtained from the total alkaloids containing as majFarmacognosia 27 (2017) 77–83
the second major compound (Rasamizafy et al., 1987). This alka-
loid was  also reported to occur in Annona and in other Annonaceae
genus, such as Enantia, Guatteria, Isolona, Pseudovaria and Xylopia
(Lebouef et al., 1982; Lúcio et al., 2015). The compound having Rt
21.32 min was characterized as anonaine (3), by comparison of its
fragmentation pattern (m/z 265 (M+.), 264 (M+-1), 236 (M+-29),
with the literature (Jackson and Martin, 1966; Bhakuni et al., 1972).
Compound showing Rt 27.48 min, m/z 311 (M+.), 310 (M+-1),
282 (M+-29), 279 (M+-31), 266 (M+-15), 251, 181 was identiﬁed as
actinodaphnine (4), which fragmentation pattern is in accordance
to previous report (McLafferty and Stauffer, 1989). Isoboldine (1)
was characterized at Rt 27.9 min  and by its fragmentation pattern,
m/z 327 (M+.), 326 (M+-1), 310 (M+-17), 284 (M+-43), 269 (M+-58),
253 (M+-74) (Jackson and Martin, 1966). Isoboldine (1) previously
isolated from ﬁve Annona species: A. cherimola, A. glabra, A. mon-
tana, A. salzmanni and A. senegalensis (Lebouef et al., 1982; Simeón
et al., 1990; Philipov et al., 1994). In the present work, both isobol-
dine and actinodaphnine were also isolated from TA, as described
below.
The alkaloid fractions (FA5 and FA6), originated from column
chromatography (CC), were puriﬁed by PTLC and yielded isobol-
dine (1) as a brown amorphous solid. Isoboldine structure was
proposed based on its molecular weight (M 327 Da), that was
determined by GC–MS, and it is compatible with the molecular
formula C19H21O4N. Moreover, 1H and 13C NMR  chemical shift val-
ues were in accordance to those reported in the literature (Jackson
and Martin, 1966), the singlets at 6.47 and 6.74 ppm were due to
the hydrogens in carbons 3 and 8; respectively; a broad singlet at
3.83–3.84 ppm (6H) relative to the methoxy groups found carbons
2 and 10 and a singlet at 2.49 ppm, relative to the hydrogens in the
NCH3 group. Jackman et al., 1979; Soares et al., 2015 have assigned
the carbons signals in the NMR  spectra for this compound, and it
is possible to verify again the level of accordance between the data
here obtained and the literature results. Isoboldine (1) was  pre-
viously isolated from A. cherimola (Simeón et al., 1990), A. glabra,
A. montana and from several other Annonaceae species. However,
actinodaphnine (4) has been exclusively isolated from Guatteria
scandens (Hocquemiller et al., 1983), and it is being here reported
as novelty for the Annona genus. This alkaloid was reported
to occur ubiquitously in Hernandiaceae and Lauraceae species
(Guinaudeau et al., 1983; Hocquemiller et al., 1983; Sulaiman et al.,
2011).
Nornuciferine (2) and anonaine (3) (Hasrat et al., 1997) had their
structures proposed based on chemical shift values recorded in
a 200 MHz  spectrometer, once they were found as a mixture in
rom the crude extract obtained from the stem of Annona hypoglauca Mart. and its
Enterococcus faecalis ATCC 29212 Escherichia coli
ATCC 25922
MIC (g/ml) MBC (g/ml) MIC  (g/ml)
>100 >100 >100
>100 >100 >100
>100 >100 >100
>100 >100 >100
>100 >100 >100
50 50 >100
NT NT NT
40 40 >100
40 40 90
8 8 0.40
32 32 2
ested. FHex, fraction hexane, DCM/MeOH, fraction dichloromethane and methanol,
or components isoboldine and actinodaphnine, respectively.
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Fig. 1. Cytotoxic activity observed after treatments with crude extract, total alka-
loids (TA), alkaloid-free fractions described as hexane fraction (FHex), butanol
fraction (FBuOH), dichloromethane/methanol fraction and ethyl acetate fraction
(FEAC), from stem of Annona hypoglauca against six human tumor cell lines.
MCF-7: breast carcinoma; PC-3: prostate carcinoma; NCI-H460: non-small cells
lung carcinoma; KM-12: colon adenocarcinoma; SF-268: glioblastoma and RPMI-
8226: multiple myeloma. * FA4.4, FA5 and FA6: column fractions obtained from
TA containing as major components isoboldine and actinodaphnine, respectively.
NI: no inhibition; NT: not tested. Graphic is interpreted as the percentage of
growth observed for the six cells after being treated. Calculations use the formula
[{(T  − T0)/(C − T0) × 100}−100 = % of growth inhibition]. Results are interpreted by
the  comparison of cell growth after treatment (T) to the cell growth at Time Zero
(T0). If 100 > T > T0 it means that treatment prevented a percentage of cells fromM.V. Rinaldi et al. / Revista Brasile
raction FA5.3 not all hydrogens could be assigned. So, nornucifer-
ne showed a doublet at 8.32 ppm (J = 7.8 Hz) corresponding to the H
t carbon 11, a singlet at 6.58 ppm for the H at carbon 3, and singlets
t 3.59 and 3.32 ppm relative to the two methoxy groups 1- and 2-
CH3. The other alkaloid, anonaine, showed a doublet at 8.00 ppm
7.8 Hz) relative to the H at carbon 11, a singlet at 6.68 relative to
he H at carbon 3 and two doublets at 5.89 and 6.28 belonging to
he methylenedioxy at carbons 1 and 2(1-O-CH2-O-2).
Actinodaphnine (4) was isolated from FA6.2 as a light brown
morphous solid. The molecular weight (M 311 Da) was deter-
ined by GC–MS and it was compatible with the molecular formula
18H17O4N. The structure of actinodaphine (4) was  attributed
ased on the comparison of NMR  spectral data with values reported
n the literature (Stévigny et al., 2002). It is possible to observe the
resence of two apparent singlets at 5.86 and 6.01 ppm that were
ttributed to the hydrogens in the methylenedioxy in position 1, 2.
he presence of a singlet referent to 3H in 3.85 ppm may  correspond
o a methoxy group as a substituent at carbon 10. The absence of
 singlet with integration to 3H next to 2.82 ppm eliminates the
ossibility of a NCH3 group, conﬁrming that compound 4 is a nora-
orphine. With these observations, it was possible to attribute that
ompound 4 is actinodaphnine. The attributions of the J values were
ompared to results found in the literature (Stévigny et al., 2002).
he purity grade of the sample permitted its analysis with different
arbon NMR  experiments to conﬁrm the structure. Actinodaphnine
as ﬁrst isolated from Annonaceae species such as G. scandens
s a brown crystal (Guinaudeau et al., 1983; Hocquemiller et al.,
983).
EB1109, hexane fraction, DCM/MeOH fraction, ethyl acetate
raction butanol fraction (Table 1) did not show a signiﬁcant
ntibacterial activity, considering that crude extracts and fractions
hould have antibacterial activity < 100 g/ml (Padma et al., 1998)
o be considered as a potential antimicrobial natural product agent.
n the other hand, TA, FA5 (major compound isoboldine (1), other
ompounds nornuciferine (2) and anonaine (3)) and FA6 (actin-
daphnine (4)) showed a moderate activity against Gram-positive
acteria (S. aureus and E. faecalis), MIC  as low as 70 and 40 g/ml,
espectively, and gives us a prospection of good antibacterial activ-
ty to actinodaphnine. Almost all samples were inactive against
he Gram-negative organism (E. coli), only FA6 (MIC > 90 g/ml)
howed some activity. Previous reports showed that isoboldine (1)
as not considered as having antibacterial activity (Villar et al.,
987; Bermejo et al., 2005) whereas anti-S. aureus activity has
een conﬁrmed to actinodaphnine (4) (Hoet et al., 2004), suppor-
ing the present ﬁndings. According to the present achievements,
he fractionation of EB1109 up to FA5 and FA6 led to an improve-
ent of the antibacterial activity and conﬁrmed actinodaphnine as
 potential antibacterial agent. The antimicrobial activity against
ram-positive bacteria of different isoquinoline compounds have
lready been studied, regarding their structure–activity relation-
hips. In these studies, aporphines demonstrated lower or no
ctivity. Only nor-aporphines bearing a 1,2-methylendioxy group
ould be considered active. A. hypoglauca accumulated at least two
porphine alkaloids, anonaine (3) and actinodaphnine (4), that con-
ain the structural requirements likely to be the responsible for the
esults observed.
Results shown in Fig. 1 and Table 2 describe the percentage
f growth and lethality observed for all treatments against can-
er cell lines. EB1109 showed cytotoxicity against breast (MCF-7)
nd colon (KM-12) cancer cell lines. The percentage of lethality
ound for breast cell lines was −32.80%. This negative value shall
e interpreted based on the time zero (T0) optical density related
o cell growth before treatment addition, so EB1109 not only killed
00% of these cells (when compared to a cell growth control with-
ut treatment), but also killed a number of the cells that grew
efore treatment. EB1109 has also shown lethality against KM-12grow; if T = T0 = 0 it means that treatment is effective to avoid cells from grow, in
relation to T0; if T < T0 it means that treatment is effective enough to cause lethality.
(−2.5%) and cytotoxicity against central nervous system cell line
SF-268 (41.5% growth inhibition), prostate cancer cell line PC-3
(88.6% of growth inhibition), leukemia cell line RPMI-8226 (82.7%
of growth inhibition) and lung cancer cell line NCI-H461 (98.7% of
growth inhibition). Total alkaloid fraction showed expressive cyto-
toxicity against MCF-7 (−8.90% of lethality) and has also shown
cytotoxicity against SF-268 (26.7% growth inhibition), against NCI-
H461 (29.0% of growth inhibition) and against KM-12 (67.6%
of growth inhibition). It was noticed that both EB1109 and TA
82 M.V. Rinaldi et al. / Revista Brasileira de Farmacognosia 27 (2017) 77–83
Table 2
Percentage of growth of cancer cell lines MCF-7 (breast), PC-3 (prostate), NCI-H460 (lung), KM-12 (colon), SF-268 (central nervous system) and RPMI-8226 (leukemia), after
treatment with organic extract of stem of Annona hypoglauca and its fractions. Negative numbers mean lethality to cell lines in relation to cell growth control and Time zero
growth control (cell growth before treatment addition).
MCF-7 PC-3 NCI-H460 KM-12 SF-268 RPMI-8226
Crude extract −32.80 11.4 1.3 −2.5 58.5 17.3
FHex  NI 77.4 48.1 NI NI 53.5
DCM/MeOH 2.90 59.6 44.9 NI 93.7 53.4
FEAC  Not tested 67.1 38.6 NI 77.4 NI
FBuOH 11.90 46.6 65.6 NI NI 83.8
TA  −8.90 17.04 71.7 32.4 73.3 NI
FA4.4  Not tested −3.8 −26.0 11.7 45.4 29.7
FA5a −11.60 Not tested Not tested −14.4 Not tested Not tested
FA6a −3.10 Not tested Not tested −8.4 Not tested Not tested
DOXO −16.31 −50.0 −46.2 −5.1 −34.0 −14.3
FHex, fraction hexane; DCM/MeOH, fraction dichloromethane and methanol; FEAC, fraction ethyl acetate; FBuOH, fraction butanol; TA, total alkaloid fraction; DOXO,
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a FA5 and FA6 are column fractions obtained from the total alkaloids containing 
nhibited breast cancer cell lines, and that may  indicate that the
lkaloids are responsible to the cytotoxicity against breast can-
er cell line. None of the fractions obtained from the cake showed
ethality, although have shown cytotoxicity, as DCM/MeOH frac-
ion, which showed growth inhibition of 97.1% against breast
ancer cell line and BuOH fraction, which inhibited in 88.1% the
rowth of the same cell. FA5 and FA6 were tested only against MCF-
 and KM-12. It was observed a lethality of 11.6% against MCF-7
reast cancer cell line and 14.4% against colon cancer cell line KM-
2 for fraction FA5. Isoboldine is the major compound of fraction
A5, which contains yet nornuciferine and anonaine. Nornucifer-
ne showed leishmanicidal activity against Leishmania mexicana
nd L. panamensis (Montenegro et al., 2003) Anonaine, as isolated
rom diverse Annonaceae and Magnoliaceae species is found to
e active as antiplasmoidal, antimicrobial, antioxidant, anticancer,
ntidepressant and vasorelaxant (Li et al., 2013). In silico analy-
is of anonaine led to the identiﬁcation of its potential to inhibit
opoisomerase II, one of the crucial targets against cancers (Singh
t al., 2016). FA6 has also shown a lethal effect, although weaker,
gainst the cell lines of breast cancer MCF-7 (−3.1%) and colon can-
er KM-12 (−8.4%). Actinodaphnine (4) was found in this fraction.
porphinoid alkaloids bearing a methylenedioxy group, such as
ctinodaphnine (4), exhibited a high afﬁnity to the DNA molecule
emonstrating a cytotoxic activity in vitro and a non-speciﬁc inhi-
ition of the Topoisomerase I activity through DNA intercalation
Hoet et al., 2004). In our ﬁndings, fraction FA5, which contains
soboldine (1), nornuciferine (2) and anonaine (3), was more efﬁ-
ient than FA6, the fraction containing actinodaphnine. Further
tudies related to structure–activity relationship are needed to elu-
idate differences in biological activity related to Annona alkaloids.
oreover, fraction FA4.4, obtained from fraction FA4 by CCD, was
ested and results showed its signiﬁcant lethality against lung can-
er cell line NCI-H460 (−26.0%) and prostate cancer PC-3 (−3.8%),
nd showing a growth inhibition against the cell lines of CNS can-
er SF-268 (54.6%), leukemia RPMI-8226 (70.3%) and colon cancer
M-12 (88.3%). It is clear that the total alkaloid fraction and their
ractions FA5 and FA6 have shown an excellent tumor cell lethality
n comparison to any of the fractions obtained from the cake, and
learly, the alkaloids are responsible for the signiﬁcant cytotoxic
ctivity, but maybe the presence of other compounds may  induce
ome synergism observed in the extreme good activity of the crude
xtract. Also, fraction FA4.4 has shown a different cytotoxicity pro-
le, because it was the only fraction among all tested that revealed
n extreme good activity against lung cancer cell line, although no
lkaloid has been identiﬁed from that fraction so far. The stronger
ffect observed for the crude extract might be explained by a syn-
rgism among the alkaloids and the other metabolites present in
he extract.or components isoboldine and actinodaphnine, respectively.
Conclusions
The present results demonstrated that A. hypoglauca showed
an improvement of its antibacterial activity, as fractionation was
performed, maybe due to the presence of actinodaphnine. Actin-
odaphnine, the alkaloid present in FA6, may  also be the responsible
for the fraction cytotoxicity, but the presence of isoboldine, nornu-
ciferine and anonaine may  have synergistically contributed to the
expressive lethality to breast cancer cells, if compared to FA6. This
is the ﬁrst report for the occurrence of actinodaphnine in Annona
species. Also, EB1109, TA, FA5 and FA6 showed signiﬁcant cyto-
toxic activity against breast and colon cancer cell lines. Finally, the
identiﬁcation of such enthusiastic results led us to pursue new evi-
dences of biological activities related to A. hypoglauca, as well as to
achieve results on its toxic activities in the future.
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